T Bourke1, D Keane. 1. Cardiac Arrhythmia Service, St Vincent's University Hospital, Elm Park, Dublin, Ireland. tarabourke@hotmail.com
Abstract
BACKGROUND: Neuromuscular disorders are not among the common causes of cardiomyopathy in the general population; however, cardiomyopathy is known to occur in several neuromuscular disorders including Friedreich's Ataxia (FA). In patients with neuromuscular disorders, concomitant cardiac involvement contributes significantly to morbidity and mortality and often leads to premature death. METHODS: An extensive literature search of Medline and Pubmed was conducted to include all published reports on cardiac involvement in FA. Secondary articles were identified from key paper reference listings. CONCLUSION: Hypertrophic cardiomyopathy is a cardinal feature of FA; therefore all FA patients should be screened for cardiomyopathy. A cardiac examination, ECG and ECHO are advised at diagnosis, and also on the development of any cardiac symptoms. Treatment is determined by the presence of symptoms, the presence of left ventricular outflow gradient and the sudden death risk. Institution of aggressive medical therapy early in the course of the disease may help improve quality of life and provide survival benefit.
BACKGROUND:Neuromuscular disorders are not among the common causes of cardiomyopathy in the general population; however, cardiomyopathy is known to occur in several neuromuscular disorders including Friedreich's Ataxia (FA). In patients with neuromuscular disorders, concomitant cardiac involvement contributes significantly to morbidity and mortality and often leads to premature death. METHODS: An extensive literature search of Medline and Pubmed was conducted to include all published reports on cardiac involvement in FA. Secondary articles were identified from key paper reference listings. CONCLUSION:Hypertrophic cardiomyopathy is a cardinal feature of FA; therefore all FA patients should be screened for cardiomyopathy. A cardiac examination, ECG and ECHO are advised at diagnosis, and also on the development of any cardiac symptoms. Treatment is determined by the presence of symptoms, the presence of left ventricular outflow gradient and the sudden death risk. Institution of aggressive medical therapy early in the course of the disease may help improve quality of life and provide survival benefit.
Authors: J Segovia; L Alonso-Pulpon; R Burgos; L Silva; S Serrano; E Castedo; J Jiménez; R Fuentes; A Cañas; J Ugarte Journal: J Heart Lung Transplant Date: 2001-02 Impact factor: 10.247
Authors: Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy Journal: Circulation Date: 2009-03-26 Impact factor: 29.690
Authors: Lars G C Luethje; Carsten Boennemann; Lev Goldfarb; Hans H Goebel; Martin Halle Journal: Pacing Clin Electrophysiol Date: 2004-04 Impact factor: 1.976
Authors: Nishaki Mehta; Paul Chacko; James Jin; Tam Tran; Thomas W Prior; Xin He; Gunjan Agarwal; Subha V Raman Journal: Tex Heart Inst J Date: 2016-08-01
Authors: Danúbia Sá-Caputo; Laisa Paineiras-Domingos; Rafaelle Carvalho-Lima; Glenda Dias-Costa; Patrícia de Castro de Paiva; Claudia Figueiredo de Azeredo; Roberto Carlos Resende Carmo; Carla F Dionello; Eloá Moreira-Marconi; Éric Heleno F F Frederico; Cintia Renata Sousa-Gonçalves; Danielle S Morel; Dulciane N Paiva; Núbia C P Avelar; Ana C Lacerda; Carlos E V Magalhães; Leonardo S Castro; Giuseppe A Presta; Severo de Paoli; Borja Sañudo; Mario Bernardo-Filho Journal: Afr J Tradit Complement Altern Med Date: 2017-07-07
Authors: Laura R Rodríguez; Tamara Lapeña; Pablo Calap-Quintana; María Dolores Moltó; Pilar Gonzalez-Cabo; Juan Antonio Navarro Langa Journal: Antioxidants (Basel) Date: 2020-07-24
Authors: Petya Bogdanova-Mihaylova; Helena Maria Plapp; Hongying Chen; Anne Early; Lorraine Cassidy; Richard A Walsh; Sinéad M Murphy Journal: Tomography Date: 2021-12-08
Authors: María Jesús Valero; Jose L Muñoz-Blanco; Alejandro Garrido Sanchez; Gregorio Cuerpo; Javier Castrodeza; Paula Navas; Iago Sousa; Adolfo Villa; Francisco Fernández-Avilés; Manuel Martínez-Sellés Journal: J Cardiovasc Dev Dis Date: 2022-03-09